ARS制药公司宣布,其与CVS Caremark的提案已进入审批流程的最后阶段。公司预计将在6月初提供一份明确的更新信息,以披露该提案的最终结果。
ARS制药公司宣布,其与CVS Caremark的提案已进入审批流程的最后阶段。公司预计将在6月初提供一份明确的更新信息,以披露该提案的最终结果。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.